glp-1 side effects pancreatitis New data links agonists for weight loss with higher risk for pancreatitis, GI events Implications of the glp-1 era
Description
However, individuals who have type 2 diabetes alongside a need to minimise weight gain or promote weight loss may benefit from GLP-1/GIP therapy and its dual impact on type 2 diabetes management and weight loss
Scott Gottlieb joins 'Squawk Box' to discuss Amgen's new injectable weight loss drugs, how it takes a different approach from other weight loss drugs like Wegovy and Mounjaro, state of the obesity drug market, and more
The company recently spent $3.8 billion to acquire three vaccine-focused businesses: Curevo, LimmaTech Biologics AG, and Vaccine Company
.webp)
Food is the conductor
